MD
De Kraker, Marlieke
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A comparison of frequentist and Bayesian approaches to the Personalised Randomised Controlled Trial (PRACTical)-design and analysis considerations | BMC Medical research methodology |  | 2025 | 23 | 15 | ||
| How to : share and reuse data-challenges and solutions from predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance project | Clinical microbiology and infection | | 2025 | 41 | 41 | ||
| Association between Charlson Comorbidity Index and positive blood cultures at a tertiary-care hospital in Indonesia | PLOS global public health | | 2025 | 26 | 35 | ||
| Reserve antibiotics : overcoming limitations of evidence generated from regulatory approval trials | Globalization and health | | 2025 | 31 | 79 | ||
| Secular trends of bloodstream infections in hemodialysis patients : insights from a longitudinal Swiss study | Antimicrobial resistance and infection control | | 2025 | 17 | 22 | ||
| Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections | Clinical microbiology and infection | | 2025 | 17 | 17 | ||
| Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM) : a systematic review and Delphi survey | Clinical microbiology and infection |  | 2024 | 73 | 0 | ||
| Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies | Eurosurveillance | | 2024 | 51 | 42 | ||
| The scope of the antimicrobial resistance challenge | Lancet | | 2024 | 66 | 0 | ||
| In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza : a retrospective, nationwide cohort study in Switzerland | Clinical infectious diseases | | 2024 | 51 | 99 | ||
| Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales : a nested case-control-control study | Journal of antimicrobial chemotherapy | | 2024 | 68 | 62 | ||
| Antimicrobial resistance in Enterobacterales infections among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | | 2024 | 102 | 239 | ||
| Attributable mortality of infections caused by carbapenem-resistant Enterobacterales : results from a prospective, multinational case-control-control matched cohorts study (EURECA) | Clinical microbiology and infection | | 2024 | 91 | 77 | ||
| Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland | JAMA network open | | 2023 | 113 | 92 | ||
| Excess resource use and cost of drug-resistant infections for six key pathogens in Europe : a systematic review and Bayesian meta-analysis | Clinical microbiology and infection | | 2023 | 86 | 112 | ||
| Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections | JAMA network open | | 2023 | 103 | 54 | ||
| Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA) : a prospective cohort study | The Lancet. Infectious diseases | | 2023 | 115 | 131 | ||
| Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland | Emerging infectious diseases | | 2023 | 120 | 200 | ||
| Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit ? | Expert opinion on biological therapy | | 2023 | 68 | 0 | ||
| Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales : a case-control study | Clinical microbiology and infection | | 2023 | 114 | 0 | ||
| Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe : a systematic review | Clinical microbiology and infection | | 2023 | 133 | 139 | ||
| Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment : gaps, heterogeneity, and bias | Clinical microbiology and infection | | 2023 | 181 | 87 | ||
| A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe | Clinical microbiology and infection | | 2023 | 88 | 99 | ||
| Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) | EClinicalMedicine | | 2023 | 92 | 35 | ||
| Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza : a large retrospective cohort study | Antimicrobial resistance and infection control | | 2023 | 78 | 89 | ||
| Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries | PLoS medicine | | 2023 | 132 | 85 | ||
| Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital | Journal of global antimicrobial resistance | | 2022 | 100 | 72 | ||
| Global burden of antimicrobial resistance: essential pieces of a global puzzle | Lancet | | 2022 | 210 | 209 | ||
| The first WHO global survey on infection prevention and control in health-care facilities | Lancet. Infectious diseases | | 2022 | 197 | 546 | ||
| Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review | Antimicrobial resistance and infection control | | 2022 | 186 | 491 | ||
| Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases | Clinical microbiology and infection | | 2022 | 223 | 64 | ||
| Lower risk of peripheral venous catheter-related bloodstream infection by hand insertion | Antimicrobial resistance and infection control | | 2022 | 206 | 123 | ||
| Implementation of hand hygiene in health-care facilities: results from the WHO Hand Hygiene Self-Assessment Framework global survey 2019 | Lancet. Infectious diseases | | 2022 | 332 | 278 | ||
| Results of an international pilot survey on healthcare environmental hygiene at the facility level | American journal of infection control | | 2022 | 142 | 0 | ||
| Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria | Clinical microbiology and infection | | 2021 | 176 | 110 | ||
| Burden of Antimicrobial Resistance: Compared to What? | Epidemiologic reviews | | 2021 | 70 | 60 | ||
| Surveillance of resistance to new antibiotics in an era of limited treatment options | Frontiers in medicine | | 2021 | 249 | 135 | ||
| The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study | Critical care | | 2021 | 237 | 93 | ||
| Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients | Clinical Microbiology and Infection | | 2021 | 286 | 339 | ||
| Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters | JAMA internal medicine | | 2021 | 230 | 0 | ||
| A one health framework to estimate the cost of antimicrobial resistance | Antimicrobial resistance and infection control | | 2020 | 216 | 55 | ||
| Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus | The Journal of Antibiotics | | 2020 | 214 | 141 | ||
| Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study | Clinical Microbiology and Infection | | 2020 | 257 | 1 | ||
| Antibacterial efficacy of handrubbing for 15 versus 30 seconds: EN 1500-based randomized experimental study with different loads of Staphylococcus aureus and Escherichia coli | Clinical Microbiology and Infection | | 2019 | 277 | 1 | ||
| Impact of participation in a surgical site infection surveillance network: results from a large international cohort study | Journal of Hospital Infection | | 2019 | 390 | 235 | ||
| Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net | Clinical Infectious Diseases | | 2018 | 354 | 186 | ||
| Shining a light on ultraviolet-C disinfection: No golden promises for infection prevention | American Journal of Infection Control | | 2018 | 432 | 0 | ||
| Wiping Is Inferior to Rubbing: A Note of Caution for Hand Hygiene With Alcohol-Based Solutions | Infection Control and Hospital Epidemiology | | 2018 | 363 | 0 | ||
| Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS) | BMJ Open | | 2018 | 582 | 267 | ||
| Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions | Clinical Microbiology and Infection | | 2017 | 582 | 0 | ||
| The global hand-sanitizing relay: promoting hand hygiene through innovation | Journal of Hospital Infection | | 2017 | 492 | 1 | ||
| World Health Organization SAVE LIVES: Clean Your Hands global campaign-'Fight antibiotic resistance-it's in your hands' | Clinical Microbiology and Infection | | 2017 | 469 | 1 | ||
| Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net | Intensive Care Medicine | | 2017 | 514 | 294 | ||
| Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? | PLOS Medicine | | 2016 | 559 | 282 |
